Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Wilcox

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
BMC Proceedings|July 3, 2025
Urinary tract infection in adults: gaps in current guidelines - opinions from an international multidisciplinary panel and relevance to clinical practiceKalpana Gupta, Florian Wagenlehner, Mark Wilcox, et al.
The Journal of Hospital Infection|February 1, 2026
Infection Prevention and Control risk assessment and policy for respiratory viral infections in NHS trusts in England: a national surveyClare Foster, Dale Weston, Laura Maynard Smith, et al.
Plos One|April 13, 2018
Subtyping of Clostridium difficile PCR ribotypes 591, 106 and 002, the dominant strain types circulating in Medellin, ColombiaClara Lina Salazar, Catalina Reyes, Astrid Vanessa Cienfuegos-Gallet, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 2008
Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial ChemotherapyR G Masterton, A Galloway, G French, et al.
Intensive Care Medicine|March 21, 2015
Preventive and therapeutic strategies in critically ill patients with highly resistant bacteriaMatteo Bassetti, Jan J De Waele, Philippe Eggimann, et al.
The Journal of Infection|February 12, 2021
Critical evaluation of the methodology used by Wilson-Davies et al., (2020) entitled "Concerning the Optigene Direct LAMP assay, and it`s use in at-risk groups and hospital staff"Dr Veronica Fowler, Dr Angela Douglas, Professor Keith Godfrey, et al.
Frontiers in Microbiology|October 19, 2020
A Novel, Orally Delivered Antibody Therapy and Its Potential to Prevent <i>Clostridioides difficile</i> Infection in Pre-clinical ModelsApril K Roberts, Hannah C Harris, Michael Smith, et al.
Eclinicalmedicine|October 7, 2025
Evaluation of SARS-CoV-2 lateral flow device sensitivity: a comparison of systematic laboratory assessments with manufacturer-reported sensitivityRaghavendran Kulasegaran-Shylini, Abbie Bown, Tom Collinge, et al.
Plos One|June 1, 2011
Clinical Clostridium difficile: clonality and pathogenicity locus diversityKate E Dingle, David Griffiths, Xavier Didelot, et al.
Applied Health Economics and Health Policy|June 2, 2025
Correction: Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in EnglandBeth Woods, Ben Kearns, Laetitia Schmitt, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
BMC Proceedings|July 3, 2025
Urinary tract infection in adults: gaps in current guidelines - opinions from an international multidisciplinary panel and relevance to clinical practiceKalpana Gupta, Florian Wagenlehner, Mark Wilcox, et al.
The Journal of Hospital Infection|February 1, 2026
Infection Prevention and Control risk assessment and policy for respiratory viral infections in NHS trusts in England: a national surveyClare Foster, Dale Weston, Laura Maynard Smith, et al.
Plos One|April 13, 2018
Subtyping of Clostridium difficile PCR ribotypes 591, 106 and 002, the dominant strain types circulating in Medellin, ColombiaClara Lina Salazar, Catalina Reyes, Astrid Vanessa Cienfuegos-Gallet, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 2008
Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial ChemotherapyR G Masterton, A Galloway, G French, et al.
Intensive Care Medicine|March 21, 2015
Preventive and therapeutic strategies in critically ill patients with highly resistant bacteriaMatteo Bassetti, Jan J De Waele, Philippe Eggimann, et al.
The Journal of Infection|February 12, 2021
Critical evaluation of the methodology used by Wilson-Davies et al., (2020) entitled "Concerning the Optigene Direct LAMP assay, and it`s use in at-risk groups and hospital staff"Dr Veronica Fowler, Dr Angela Douglas, Professor Keith Godfrey, et al.
Frontiers in Microbiology|October 19, 2020
A Novel, Orally Delivered Antibody Therapy and Its Potential to Prevent <i>Clostridioides difficile</i> Infection in Pre-clinical ModelsApril K Roberts, Hannah C Harris, Michael Smith, et al.
Eclinicalmedicine|October 7, 2025
Evaluation of SARS-CoV-2 lateral flow device sensitivity: a comparison of systematic laboratory assessments with manufacturer-reported sensitivityRaghavendran Kulasegaran-Shylini, Abbie Bown, Tom Collinge, et al.
Plos One|June 1, 2011
Clinical Clostridium difficile: clonality and pathogenicity locus diversityKate E Dingle, David Griffiths, Xavier Didelot, et al.
Applied Health Economics and Health Policy|June 2, 2025
Correction: Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in EnglandBeth Woods, Ben Kearns, Laetitia Schmitt, et al.
Pageof 8